Elevation Point Wealth Partners LLC Invests $1.06 Million in Corteva, Inc. $CTVA

Elevation Point Wealth Partners LLC acquired a new stake in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, HoldingsChannel reports. The fund acquired 12,464 shares of the company’s stock, valued at approximately $1,056,000.

A number of other institutional investors have also recently made changes to their positions in the business. William B. Walkup & Associates Inc. boosted its position in Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares during the period. Wilkerson Advisory Group LLC grew its stake in shares of Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. AdvisorNet Financial Inc increased its position in shares of Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after acquiring an additional 135 shares during the period. First Horizon Corp increased its position in shares of Corteva by 9.2% during the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock worth $134,000 after acquiring an additional 135 shares during the period. Finally, Aviance Capital Partners LLC raised its stake in shares of Corteva by 1.3% in the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after acquiring an additional 137 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

Corteva stock opened at $82.74 on Tuesday. The stock has a market cap of $55.21 billion, a P/E ratio of 54.80, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57. The company has a fifty day simple moving average of $82.27 and a 200-day simple moving average of $80.32. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. BNP Paribas Exane lifted their target price on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Morgan Stanley upped their price target on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Citigroup increased their price target on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. lifted their price objective on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Finally, Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.